Harvest Investment Services LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,855 shares of the biotechnology company's stock, valued at approximately $1,697,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. Vanguard Group Inc. boosted its holdings in shares of Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Axon Enterprise by 3.7% during the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after purchasing an additional 65,097 shares during the last quarter. Capital World Investors increased its position in shares of Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after acquiring an additional 841,772 shares during the last quarter. Alliancebernstein L.P. raised its position in Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after purchasing an additional 812,337 shares during the period. Finally, Norges Bank purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at $482,081,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on AXON. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays reissued a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $626.45.
Get Our Latest Stock Report on AXON
Axon Enterprise Price Performance
Shares of Axon Enterprise stock traded up $13.11 during trading on Friday, hitting $603.78. 556,214 shares of the company were exchanged, compared to its average volume of 777,156. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm has a 50 day moving average price of $545.51 and a 200 day moving average price of $570.72. The stock has a market capitalization of $47.00 billion, a price-to-earnings ratio of 156.02, a P/E/G ratio of 5.17 and a beta of 1.13.
Insider Buying and Selling
In other news, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.